Ms. Pote et al., AN ANTIATHEROGENIC ROLE FOR FOLIC-ACID IN EXPERIMENTAL DIABETES, Journal of clinical biochemistry and nutrition, 18(3), 1995, pp. 157-164
The effect of folic acid on lipoprotein lipase and various lipid fract
ions was studied in streptozotocin-induced diabetic rats. An enhanced
plasma and hepatic lipoprotein lipase activity has been observed in fo
late supplemented diabetic animals. The proatherogenic triglycerides a
nd very-low-density lipoprotein cholesterol+low-density lipoprotein ch
olesterol levels were found to be elevated in the diabetic groups, and
folic acid supplementation lowered these levels. A significant increa
se in the antiatherogenic high-density lipoprotein cholesterol levels
was observed in the diabetic rats on folate supplementation. The ratio
of total cholesterol to high-density lipoprotein cholesterol of 3.93/-1.56 observed in the diabetic groups was lowered to 2.04+/-0.25 on f
olate supplementation. These observations suggest a role for folic aci
d as an antiatherogenic agent in experimentally induced diabetes.